Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

Losing weight and sustaining a healthy weight are notoriously difficult. If you’re struggling to reach your weight goals, you ...

The global surge in diabetes cases is a key factor propelling the artificial pancreas device market, as a larger patient base fuels the need for effe ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

When it rebranded as WW, it looked like the writing was on the wall for WeightWatchers. BBD Perfect Storm Health’s Nick ...

In recent years, healthcare navigation has gone from being viewed as a nice-to-have to a must-have by many self-insured ...

A video showing a young child trying to wake her father up after his glucose levels go too low is making parents question ...